Not Tagged
Not Tagged
[]
biosimilar vs originator: as switches loom in the us, once again it s really hard to say we see any differences in drug survival for our ra patients these data from forced switching in bc, canada are just like the others - biosimilars are business as usual. pos0567 #eular2023 
Rheumatologist and clinical pharmacologist, world traveller pretences on the upswing, sometimes journal podcast host. All opinions my own